NYC Startup Syntimmune Names Former Biogen Exec as New CEO Post author:Sam Post published:January 2, 2018 Post category:BioPharma Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace You Might Also Like Bay Area's ChemoCentryx Gets Up to $100M in New Capital Commitments January 3, 2018 It's Official: VWR Sold in $6.4 Billion Deal May 4, 2017 Shire in Talks to Sell 100-Employee Facility in Massachusetts October 29, 2017
